Circulating miRNA analysis for cancer diagnostics and therapy.

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Early cancer diagnosis and therapy monitoring are crucial for successful treatment outcomes.
• Traditional tumor biopsies have limitations in sensitivity, specificity, and applicability for continuous patient monitoring.
• Liquid biopsies provide a minimally invasive, cost-efficient alternative for cancer detection and monitoring.

Purpose of the Study:

• To provide a comprehensive overview of circulating microRNA (miRNA) analysis in liquid biopsies.
• To highlight the importance of sampling, quality control, and technical aspects of miRNA analysis.
• To summarize recommendations for downstream analysis and discuss future perspectives in the field.

Main Methods:

• Review of current literature on circulating miRNA analysis.
• Discussion of technical procedures including miRNA extraction and quantification.
• Analysis of sampling and quality control considerations for liquid biopsies.

Main Results:

• Circulating miRNAs represent a novel and promising class of biomarkers for cancer diagnosis and monitoring.
• Standardization of sampling, quality control, and analytical methods is essential for reliable miRNA analysis.
• Significant advancements have been made in the utilization of miRNAs for early cancer detection.

Conclusions:

• Circulating miRNA analysis in liquid biopsies is a rapidly advancing field with high potential for clinical application.
• Further development and standardization are expected to enhance the utility of miRNAs as cancer biomarkers.
• Liquid biopsies, particularly those utilizing miRNAs, are poised to revolutionize cancer care through improved diagnostics and monitoring.